Evidence map›Paper›PMID 32454648›Full record

ArticleTurkish journal of pharmaceutical sciences2018

Anti-inflammatory Effects of

Ahmet Cumaoğlu, Gökçe Şeker Karatoprak, Mükerrem Betül Yerer, Müberra Koşar

Open access · diamondAbstract read
In one paragraph

Article in Turkish journal of pharmaceutical sciences, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Chemical Composition and Biological Activities ofMolecules (Basel, Switzerland) · 2025
    Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Ahmet CumaoğluErciyes University, Faculty of Pharmacy, Department of Biochemistry, Kayseri, Turkey.ORCID https://orcid.org/0000-0002-3997-7746
Gökçe Şeker KaratoprakErciyes University, Faculty of Pharmacy, Department of Pharmacognosy, Kayseri, Turkey.ORCID https://orcid.org/0000-0001-5829-6914
Mükerrem Betül YererErciyes University, Faculty of Pharmacy, Department of Pharmacology, Kayseri, Turkey.ORCID https://orcid.org/0000-0002-4503-8032
Müberra KoşarErciyes University, Faculty of Pharmacy, Department of Pharmacognosy, Kayseri, Turkey.ORCID https://orcid.org/0000-0002-1559-998X
Erciyes University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThis study was designed to investigate the anti-inflammatory effects of MATERIALS AND

methodsTo measure the effects of root extracts on pro-inflammatory mediators, we used the following methods: 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay (cell viability or cytotoxcicity), enzyme-linked immunosorbent assay (cytokine production, prostoglandin E2 production), reverse transcriptase-polymerase chain reaction (COX-2, iNOS mRNA), Western blotting analysis [MAPK activation and NF-κB (p65) traslocation] and the Griess reaction (NO production).

resultsStimulation of the RAW 264.7 cells with LPS (0.5 µg/mL, 6 hrs treatment) caused an elevated production of pro-inflammatory cytokines (TNF-α and IL-6), increased mRNA expression of COX-2 and inducible NO synthase with release of PGE2 and NO, activated MAPK (phosphorylation of c-Jun N-terminal kinase, extracellular signal-regulated kinase, P38) signalling pathway, and nuclear translocation of NF-κB (p65), which were markedly inhibited by the pre-treatment with 11% ethanol and 70% methanol root extracts of

conclusionOur data indicate that especially 11% ethanol root extract of

Indexed as

cyclooxygenase-2cytokinesinflammationmacrophagesPelargonium species

Identifiers

PMID32454648
PMCPMC7227898
OpenAlexW2796299767

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.